Drawing for BSP PHARMACEUTICALS

USPTO serial 79355934

BSP PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 7282466Status 700Registered
Filing date
Status date
Registration date
Jan 23, 2024
Examiner
MASON, JARED MICHAEL

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BSP PHARMACEUTICALS?

CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.

Owner

  • BSP PHARMACEUTICALS S.p.A.

    IT

  • BSP PHARMACEUTICALS S.p.A.

    IT

  • BSP PHARMACEUTICALS S.p.A.

    IT

  • BSP PHARMACEUTICALS S.p.A.

    IT

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of cancerACTIVE
042Research and development services in the medical and pharmaceutical fields, namely, pharmaceutical research and development; services for the development and testing of pharmaceutical products, for third partiesACTIVE

Prosecution history

DateCodeEventWhat it means
May 22, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 25, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 25, 2024FIMPFINAL DISPOSITION PROCESSED
Apr 23, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 6, 2023GPNXNOTIFICATION PROCESSED BY IB
Oct 18, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 18, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 18, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023RFNTREFUSAL PROCESSED BY IB
Oct 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 12, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 12, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 7, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 7, 2023RFRRREFUSAL PROCESSED BY MPU
Aug 18, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 17, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2023DOCKASSIGNED TO EXAMINER
Nov 29, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Nov 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance